Cover Image

Effect of capecitabine on breast cancer patients with different estrogen receptor status

This meta-analysis is to compare the efficacy of capecitabine versus non-capecitabine chemotherapy on breast cancer patients with different estrogen receptor (ER) status. We searched relevant literatures from EMBASE, PubMed and OVID library to analyze pathologic complete response rate (PCR), overall...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gang Xu (Author), Xin Lv (Author), Ke Lu (Author), Ming Hai Shen (Author), Qing Hua Zhang (Author), Wan Neng Pan (Author)
Format:	Book
Published:	Bangladesh Pharmacological Society, 2020-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of estrogen receptor beta in breast cancer
by: Yujing Zhou, et al.
Published: (2020)

Estrogen and progesterone receptor expression in breast carcinoma
by: TB Pathak, et al.
Published: (2011)

A novel oncogenic enhancer of estrogen receptor-positive breast cancer
by: Chunjie Bao, et al.
Published: (2022)

Schisandrol A Exhibits Estrogenic Activity via Estrogen Receptor α-Dependent Signaling Pathway in Estrogen Receptor-Positive Breast Cancer Cells
by: Dahae Lee, et al.
Published: (2021)

Night work and breast cancer estrogen receptor status - results from the German GENICA study
by: Sylvia Rabstein, et al.
Published: (2013)

Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
by: Downton T, et al.
Published: (2022)

The Role of Selective Estrogen Receptor Modulators on Breast Cancer: From Tamoxifen to Raloxifene
by: Wen-Ling Lee, et al.
Published: (2008)

Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist
by: Folasade R. Olayoku, et al.
Published: (2023)

Role of estrogen receptor coregulators in endocrine resistant breast cancer
by: Kristin A. Altwegg, et al.
Published: (2021)

Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future
by: Jiaqi Yao, et al.
Published: (2023)

Fructus mume Extracts Alleviate Diarrhea in Breast Cancer Patients Receiving the Combination Therapy of Lapatinib and Capecitabine
by: Hua Xing, et al.
Published: (2018)

Integrative analysis of histopathological images and chromatin accessibility data for estrogen receptor-positive breast cancer
by: Siwen Xu, et al.
Published: (2020)

Exploring The Impact of Capecitabine Treatment on Hormonal and Biochemical Markers in Women with Breast Cancer
by: Raaid Fadhl Abbas Masoudi, et al.
Published: (2023)

Primary estrogen receptor-positive lung adenocarcinoma identified by immunohistochemical investigation of rare cutaneous metastasis to the breast in a patient with presumed recurrent estrogen receptor-positive breast cancer
by: Shu Ting Liang (Amy), et al.
Published: (2021)

Comparison of estrogens and estrogen metabolites in human breast tissue and urine
by: Veenstra Timothy D, et al.
Published: (2010)

Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status
by: Anogiannaki Nektaria, et al.
Published: (2005)

New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives
by: Jian Min, et al.
Published: (2024)

Sodium iodide symporter, estrogen receptor, and progesterone receptor expression in carcinoma breast - An immunohistochemical analysis
by: Ashwani Tandon, et al.
Published: (2011)

Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
by: Yubo Wang, et al.
Published: (2023)

Hepatic toxicity in HER-2(+) breast cancer patient under treatment with capecitabine and lapatinib
by: Elia Romero Carreño, et al.
Published: (2016)

Endometrial expression of leukemia inhibitory factor in women with different estrogen/progesterone receptor status of the endometrium
by: S. S. Aganezov, et al.
Published: (2019)

Placental expression of estrogen receptor beta and its hormone binding variant - comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cells
by: Henley Donald C, et al.
Published: (2003)

New and emerging treatments for estrogen receptor-positive breast cancer: focus on everolimus
by: Paplomata E, et al.
Published: (2013)

Hand-foot syndrome due to capecitabine
by: Surjushe Amar, et al.
Published: (2009)

Hand-foot syndrome due to capecitabine
by: Surjushe Amar, et al.
Published: (2008)

Estrogens and breast cancer
by: HANKINSON SUSAN E, et al.
Published: (1997)

A comparative analysis of body mass index with estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in pre- and postmenopausal breast cancer patients
by: Richa Chauhan, et al.
Published: (2020)

Cost-effectiveness of utidelone and capecitabine versus monotherapy in anthracycline- and taxane-refractory metastatic breast cancer
by: Mulan Chen, et al.
Published: (2024)

The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer-A Meta-Analysis
by: Zilin Zhang, et al.
Published: (2021)

Henna Application in the Prevention of Capecitabine-Induced Hand-Foot Syndrome in Breast and Colorectal Cancer Patients
by: Emel Emine Kayikci, et al.
Published: (2020)

Role of estrogen receptors in cancer: a special emphasis on the therapeutic potential of estrogen receptor β
by: Emdormi Rymbai, et al.
Published: (2022)

Association of Interleukin 6 with Positive Immunohistochemical staining of Estrogen Receptor in Breast Cancer Patients.
by: Dalya Basil Hana
Published: (2010)

High Expression of Sphingosine Kinase 1 in Estrogen and Progesterone Receptors-Negative Breast Cancer
by: Azadeh Sadat Nazouri, et al.
Published: (2017)

New Insights into Estrogen/Estrogen Receptor Effects in the Cardiac and Skeletal Muscle
Published: (2020)

Capecitabine-induced Subacute Cutaneous Lupus Erythematosus
by: Aroni Rocha, et al.
Published: (2019)

Adherence and safety study in patients on treatment with capecitabine
by: Francisca Fernández-Ribeiro, et al.
Published: (2017)

Research Progress of Estrogen Receptor in Ovarian Cancer
by: Mengchen Zhang, et al.
Published: (2023)

Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer
by: Maria Fernanda Imperio Pereira, et al.
Published: (2024)

Combined Effect of Sertraline and Capecitabine on Breast Cancer Cell Lines In Vitro and In Silico Evidence for Synergistic Interaction
by: Serap Ozkaya Gul, et al.
Published: (2024)

Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases
by: Wang C, et al.
Published: (2024)